Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesBlood Transfusion, AutologousTransplantation, AutologousHematopoietic Stem Cell TransplantationWhole-Body IrradiationBlood TransfusionTransplantation ConditioningTransplantation ChimeraLeukemiaAnemia, AplasticBone Marrow DiseasesHematopoietic Stem CellsGraft SurvivalBone Marrow PurgingOperative Blood SalvageHistocompatibility TestingBone Marrow ExaminationBone RemodelingTissue DonorsBusulfanBone Marrow NeoplasmsLiver TransplantationHematopoiesisHistocompatibilityMice, Inbred C57BLTransplantation, IsogeneicCyclophosphamideRecurrenceRadiation ChimeraTreatment OutcomeBone DensityLeukemia, Myeloid, AcuteImmunosuppressive AgentsBlood Loss, SurgicalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsCombined Modality TherapyTime FactorsHemodilutionRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaKidney TransplantationColony-Forming Units AssayBone ResorptionGraft RejectionT-LymphocytesErythrocyte TransfusionLeukemia, MyeloidGraft vs Host ReactionStem Cell TransplantationTransplantation ImmunologyLymphocyte DepletionImmunosuppressionCell DifferentiationRetrospective StudiesHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorAcute DiseaseMyelodysplastic SyndromesLeukocyte TransfusionLymphoma, Non-HodgkinChimeraSpleenBone NeoplasmsCells, CulturedSurvival AnalysisHLA AntigensFlow CytometryHematologic DiseasesMice, Inbred BALB CSevere Combined ImmunodeficiencyGraft vs Tumor EffectPancytopeniaSurvival RateHeart TransplantationFollow-Up StudiesPlatelet TransfusionMultiple MyelomaGraft vs Leukemia EffectCyclosporineBone DevelopmentLeukocyte CountAntigens, CD34Actuarial AnalysisAntineoplastic Combined Chemotherapy ProtocolsBone DiseasesNuclear FamilyGranulocytesLymphocyte TransfusionCytomegalovirus InfectionsProspective StudiesCytarabineImmunophenotypingMice, KnockoutCarmustine